Catalyst Pharmaceuticals Inc (CPRX)

Catalyst Pharmaceuticals Inc (CPRX) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Jul 17, 2026: market cap $3.9B; returns 1 week +0.1%, 1 year +46.8%.

Catalyst Pharmaceuticals Inc. is a commercial-stage biopharmaceutical company dedicated to in-licensing, developing, and commercializing innovative medicines for patients suffering from rare and difficult-to-treat diseases, primarily within the United States.

CPRX financial model: income statement, cash flow and balance sheet